REFERENCES
- Sherwood MB, Grierson I, Milar L, et al. Long-term morphologic effects of antiglaucoma drugs on the conjunctiva and Tenon’s capsule in glaucoma patients. Ophthalmology. 1989;96:327–335.
- Valente C, Iester M. Impact of glaucoma medication on ocular tissue. Expert Rev Ophthalmol. 2010;3:405–412.
- Baudouin C. Side effects of antiglaucomatous drugs on the ocular surface. Curr Opin Ophthalmol. 1996;7:80–86.
- Khaw PT, Chang L, Wong TT, et al. Modulation of wound healing after glaucoma surgery. Curr Opin Ophthalmol. 2001;12:143–148.
- Lama PJ, Fechtner RD. Antifibrotics and wound healing in glaucoma surgery. Surv Ophthalmol. 2003;48:314–346.
- Nuzzi R, Vercelli A, Finazzo C, et al. Conjunctiva and subconjunctival tissue in primary open-angle glaucoma after long-term topical treatment: An immunohistochemical and ultrastructural study. Graefes Arch Clin Exp Ophthalmol. 1995;233:154–162.
- Shah M, Foreman DM, Ferguson MWJ. Neutralisation of TGF-β1 and TGF-β2 or exogenous addition of TGF-β3 to cutaneous rat wounds reduces scarring. J Cell Sci. 1995;108:985–1002.
- Li DQ, Meller D, Liu YQ, et al. Overexpression of MMP-1 and MMP-3 by cultured conjunctivochalasis fibroblas. Invest Ophthalmol Vis Sci. 2000;41:404–410.
- Di Girolamo N, McCluskey P, Lloyd A, et al. Expression of MMPs and TIMPs in human pterygia and cultured pterygium epithelial cells. Invest Ophthalmol Vis Sci. 2000;41:671–679.
- Davis JM. Basic Cell Culture. Oxford University Press, New York, NY, USA 1994; p. 155.
- Young TL, Higginbotham EJ, Xiaolian Z, et al. Effects of topical glaucoma drugs on fistulized rabbit on conjunctiva. Ophthalmology. 1990;97:1423–1427.
- Wu KY, Hong SJ, Wang HZ. Effects of pilocarpine and other antiglaucoma drugs on cultured human Tenon’s fibroblast cells. J Ocul Pharmacol Ther. 1997;13:13–21.
- Scuderi AC, De Lazzari A, Miano F, et al. Residence time of netilmicin in tears. Cornea. 2002;21:48–50.
- Krohn DL. Flux of topical pilocarpine to the human aqueous. Trans Am Ophthalmol Soc. 1978;76:502–527.
- Leof EB, Proper JA, Goustin AS, et al. Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor-β: A proposed model for indirect mitogenesis involving autocrine activity. Proc Natl Acad Sci U S A. 1986;83:2453–2457.
- Ravitz MJ, Wenner CE. Cyclin-dependent kinase regulation during G1 phase and cell cycle regulation by TGF-beta. Adv Cancer Res. 1997;71:165–207.
- Kothapalli D, Frazier KS, Welply A, et al. Transforming growth factor-β induces anchorage-independent growth of NRK fibroblasts via a connective tissue growth factor-dependent signaling pathway. Cell Growth Differ. 1997;8:61–68.
- Picht G, Welge-Luessen U, Grehn F, et al. Transforming growth factor β2 levels in the aqueous humor in different types of glaucoma and the relation to filtering bleb formation. Graefe’s Arch Clin Exp Ophthalmol. 2001;239:199–207.
- Kay EP, Lee HK, Park KS, et al. Indirect mitogenic effect of transforming growth factor-β on cell proliferation of subconjunctival fibroblasts. Invest Ophthalmol Vis Sci. 1998;39:481–486.
- Cordeiro MF, Bhattacharya SS, Schultz GS, et al. TGF-β1, -β2, and -β3 in vitro: Biphasic effects on Tenon’s fibroblast contraction, proliferation, and migration. Invest Ophthalmol Vis Sci. 2000;41:756–763.
- Seo JH, Park KH, Kim YJ, et al. Differences in the histopathology and matrix metalloproteinase expression in Tenon’s tissue of primary open-angle glaucoma and primary angle-closure glaucoma. Korean J Ophthalmol. 2008;22:37–42.
- Mietz H, Schlötzer-Schrebardt U, Strassfeld C, et al. Effect of latanoprost and timolol on the histopathology of the rabbit conjunctiva. Invest Ophthalmol Vis Sci. 2001;42:679–687.
- Baudouin C, Hamard P, Liang H,et al. Conjunctival epithelial cell expression of interleukins and inflammatory markers in glaucoma patients treated over the long term. Ophthalmology. 2004;111:2186–2192.
- Nordmann J-P, Auzanneau N, Ricard S, et al. Vision related quality of life and topical glaucoma treatment side effects. Health & Quality Life Outcomes. 2003;1:75.